ArticleMolecular therapy. Methods & clinical development2021

Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection.

Takuro Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.